Research progress of aspartyl-(asparaginyl) β-hydroxylase in hepatocellular carcinoma / 中华肝胆外科杂志
Chinese Journal of Hepatobiliary Surgery
; (12): 158-160, 2019.
Artigo
em Chinês
| WPRIM (Pacífico Ocidental)
| ID: wpr-745352
Biblioteca responsável:
WPRO
ABSTRACT
Hepatocellular carcinoma is characterized by a high rate of incidence,along with significant likelihood of postoperative recurrence and metastatic,whereas its underlying mechanism remains considerably unclear.The overexpression of Aspartyl/Asparaginyl beta-hydroxylase (ASPH,AAH) was initially found in hepatocellular carcinoma and cholangiocarcinoma,signifying its involving in multiple biological behaviors of hepatocellular carcinoma.Here we review recent advances on ASPH in hepatocellular carcinoma,aiming to provide a new theoretical basis for its treatment prospectively.
Texto completo:
Disponível
Base de dados:
WPRIM (Pacífico Ocidental)
Idioma:
Chinês
Revista:
Chinese Journal of Hepatobiliary Surgery
Ano de publicação:
2019
Tipo de documento:
Artigo